Found: 32
Select item for more details and to access through your institution.
Patterns of response to atomoxetine in the treatment of adult patients with Attention Deficit Hyperactivity Disorder.
- Published in:
- Klinik Psikofarmakoloji Bulteni, 2015, v. 25, p. S83
- By:
- Publication type:
- Article
A well-being programme in severe mental illness. Reducing risk for physical ill-health: A post-programme service evaluation at 2years
- Published in:
- European Psychiatry, 2007, v. 22, n. 7, p. 413, doi. 10.1016/j.eurpsy.2007.07.002
- By:
- Publication type:
- Article
Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit/Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Intramuscular Olanzapine -- a UK case series of early cases.
- Published in:
- Annals of General Psychiatry, 2007, v. 6, p. 11, doi. 10.1186/1744-859X-6-11
- By:
- Publication type:
- Article
A review of hyperprolactinaemia and severe mental illness: Are there implications for clinical biochemistry?
- Published in:
- Annals of Clinical Biochemistry, 2010, v. 47, n. 4, p. 292, doi. 10.1258/acb.2010.010025
- By:
- Publication type:
- Article
Olanzapine long-acting injection: a review of first experiences of post-injection delirium/sedation syndrome in routine clinical practice.
- Published in:
- BMC Psychiatry, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12888-015-0450-9
- By:
- Publication type:
- Article
Weight management in a cohort of Irish inpatients with serious mental illness (SMI) using a modular behavioural programme. A preliminary service evaluation.
- Published in:
- BMC Psychiatry, 2008, v. 8, p. 1
- By:
- Publication type:
- Article
Schizophrenia and Cancer: In 2010 Do We Understand the Connection?
- Published in:
- Canadian Journal of Psychiatry, 2010, v. 55, n. 12, p. 761, doi. 10.1177/070674371005501203
- By:
- Publication type:
- Article
Response to Cunill et al.
- Published in:
- 2014
- By:
- Publication type:
- Other
Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta-analysis of atomoxetine and methylphenidate comparator clinical trials.
- Published in:
- Child & Adolescent Psychiatry & Mental Health, 2013, v. 7, n. 1, p. 1, doi. 10.1186/1753-2000-7-19
- By:
- Publication type:
- Article
FeNO Variability When Using Different Analyzers at the Joint ATS/ERS Guideline Cutoff.
- Published in:
- Respiration, 2020, v. 99, n. 1, p. 93, doi. 10.1159/000503936
- By:
- Publication type:
- Article
Atomoxetine in Children and Adolescents with Attention- Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009-2011. An Update for Clinicians.
- Published in:
- Journal of Central Nervous System Disease, 2011, n. 3, p. 209, doi. 10.4137/JCNSD.S4391
- By:
- Publication type:
- Article
A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities.
- Published in:
- Neuropsychiatric Disease & Treatment, 2017, v. 13, p. 357, doi. 10.2147/NDT.S115707
- By:
- Publication type:
- Article
A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: An integrated analysis of the complete database of multicenter placebo-controlled trials.
- Published in:
- Journal of Psychopharmacology, 2014, v. 28, n. 9, p. 837, doi. 10.1177/0269881114542453
- By:
- Publication type:
- Article
Systematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009–2011: Focus on clinical efficacy and safety.
- Published in:
- Journal of Psychopharmacology, 2014, v. 28, n. 3, p. 204, doi. 10.1177/0269881113478475
- By:
- Publication type:
- Article
Systematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009-2011: focus on clinical efficacy and safety.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Weight change by baseline BMI from three-year observational data: findings from the Worldwide Schizophrenia Outpatient Health Outcomes Database.
- Published in:
- Journal of Psychopharmacology, 2013, v. 27, n. 4, p. 358, doi. 10.1177/0269881112473789
- By:
- Publication type:
- Article
Mortality in Schizophrenia.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Cancer and schizophrenia: is there a paradox?
- Published in:
- 2010
- By:
- Publication type:
- journal article
Mortality in schizophrenia: a measurable clinical endpoint.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Review: Cancer and schizophrenia: is there a paradox?
- Published in:
- Journal of Psychopharmacology, 2010, v. 24, n. S4, p. 51, doi. 10.1177/1359786810385489
- By:
- Publication type:
- Article
Review: Mortality in schizophrenia: a measurable clinical endpoint.
- Published in:
- Journal of Psychopharmacology, 2010, v. 24, n. S4, p. 17, doi. 10.1177/1359786810382468
- By:
- Publication type:
- Article
Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics.
- Published in:
- Journal of Psychopharmacology, 2008, v. 22, n. 2S, p. 56, doi. 10.1177/0269881107088436
- By:
- Publication type:
- Article
A review of the association between antipsychotic use and hyperprolactinaemia.
- Published in:
- Journal of Psychopharmacology, 2008, v. 22, n. 2S, p. 46, doi. 10.1177/0269881107088435
- By:
- Publication type:
- Article
Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics.
- Published in:
- Journal of Psychopharmacology, 2007, v. 21, n. 7, p. 768, doi. 10.1177/0269881107078281
- By:
- Publication type:
- Article
Challenges in advancing mental and physical health of patients with serious mental illness.
- Published in:
- Journal of Psychopharmacology, 2005, v. 19, n. 6S, p. 3, doi. 10.1177/0269881105058969
- By:
- Publication type:
- Article
The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link?
- Published in:
- Journal of Psychopharmacology, 2005, v. 19, n. 6S, p. 76, doi. 10.1177/0269881105058719
- By:
- Publication type:
- Article
The role of lifestyle interventions and weight management in schizophrenia.
- Published in:
- Journal of Psychopharmacology, 2005, v. 19, n. 6S, p. 28, doi. 10.1177/0269881105058682
- By:
- Publication type:
- Article
Diabetes and schizophrenia 2005: are we any closer to understanding the link?
- Published in:
- Journal of Psychopharmacology, 2005, v. 19, n. 6S, p. 56, doi. 10.1177/0269881105058379
- By:
- Publication type:
- Article